Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast

Journal of Pathology

Volumn 193, Issue 4, 2001, Pages 433-441

  Gillett, C E ^a   Miles, D W ^a   Ryder, K ^a   Skilton, D ^a   Liebman, R D ^a   Springall, R J ^a   Barnes, D M ^a   Hanby, A M ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b Pembury Hospital   (United Kingdom)

Author keywords

Cross talk; E cadherin; Grade III ductal carcinoma; Poor prognosis

Indexed keywords

ALPHA CATENIN; BETA CATENIN; BIOTIN; CATENIN; ESTROGEN RECEPTOR; PLAKOGLOBIN; STREPTAVIDIN; TAMOXIFEN; UVOMORULIN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BIOLOGY; BREAST CANCER; BREAST TUMOR; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DOWN REGULATION; FEMALE; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MEMBRANE BINDING; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ALPHA CATENIN; ANALYSIS OF VARIANCE; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; CYTOSKELETAL PROTEINS; DESMOPLAKINS; DISEASE-FREE SURVIVAL; FEMALE; GAMMA CATENIN; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL RATE; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035068950     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.831     Document Type: Article

References (48)

1. Cadherins
2. Cadherin cell adhesion receptors as a morphogenetic regulator
3. Cell adhesion molecule uvomorulin is localised in the intermediate junctions of the adult intestinal epithelial cells
4. The cadherins: Cell-cell adhesion molecules controlling animal morphogenesis
5. Catenins as mediators of the cytoplasmic functions of cadherins
6. E-cadherin null mutant embryos fail to form a trophectoderm epithelium
7. Regulation of β-catenin levels and the localisation by overexpression of plakoglobin and inhibition of the ubiquitin-proteosome system
8. Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC
9. Signal transduction through β-catenin and specification of cell fate during embryogenesis
10. β-catenin as oncogene: The smoking gun
11. Cadherins, catenins and APC protein: Interplays between cytoskeletal complexes and signalling pathways
12. Differential nuclear translocation and transactivation potential of β-catenin and plakoglobin
13. α-Catenin-vinculin interaction functions to organise the apical junctional complex in epithelial cells
14. E-cadherin expression on colorectal carcinoma: An immunocytochemical and in situ hybridization study
15. Loss of cell-cell and cell-matrix adhesion molecules in colorectal carcinoma
16. Cadherins in cancer: Implications for invasion and metastasis
17. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
18. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors
19. Loss of membranous E-cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade and advanced stage
20. E-cadherin expression in head and neck squamous cell carcinomas is associated with clinical outcome
21. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas
22. The role of adhesion molecules in cancer invasion and metastasis
23. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma
24. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
25. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas
26. E-cadherin inactivation in lobular carcinoma in situ of the breast: An early event in tumorigenesis
27. Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas
28. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
29. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer
30. P-cadherin expression in breast carcinomas indicates poor survival
31. The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast
32. E-cadherin and α-, β- and γ-catenin protein expression in relation to metastasis in human breast carcinoma
33. Expression of E-cadherin and catenins in invasive mammary carcinomas
34. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
35. Comparative hybridisation of breast tumours stratified by histological grade reveals new insights into the biological progression of breast cancer
36. Evaluation of infiltrating carcinomas with a DCIS component: Correlation of the histologic type of the in situ component with grade of the infiltrating component
37. Phenotypic drift does not happen but lots of interesting things do
38. Functional down-regulation of the E-cadherin/catenin complex leads to loss of contact inhibition of motility and of mitochondrial activity, but not of growth in confluent epithelial cultures
39. Immunophenotypic and prognostic analysis of E-cadherin and β-catenin expression during breast carcinogenesis and tumour progression: A comparative study with CD44
40. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers
41. P120ctn acts as an inhibitory regulator of cadherin function in colon carcinoma cells
42. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of β-catenin from cell-cell contacts
43. Stromelysin 3: A paradigm for stromal derived factors implicated in carcinoma progression
44. Co-ordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution
45. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
46. E-cadherin in human gastric carcinoma cell lines
47. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain
48. The expression of p120ctn protein in breast cancer is independent of α- and β-catenin and E-cadherin